Researchers discover unique suspension technique for large-scale stem cell production

April 5, 2012, University of Toronto

Post-doctoral researcher David Fluri and Professor Peter Zandstra at the University of Toronto's Institute of Biomaterials and Biomedical Engineering (IBBME) have developed a unique new technique for growing stem cells that may make possible cost-effective, large-scale stem cell manufacturing and research.

Although are widely used for the testing of , researchers have always faced difficulties manufacturing enough viable cells from a culture. Typically, stem cells are grown on surfaces that must be scraped, and which must then be differentiated from other types of cells to prevent the death of those all-important cells. This has proven to be an inefficient way to harvest stem cells, since the process doesn't produce stem cells in high enough numbers that they can be cost-effectively used by researchers.

Wanting to overcome this challenge, Fluri decided to pair the stem cell creation process, known as reprogramming, with the use of a bioreactor—an apparatus that creates stable environmental conditions. Through this process Fluri was able to "reprogram" mouse cells to become "pluripotent" stem cells—cells that can become any kind of cell—and then into cardiac cells.

But it was the way these cells were successfully grown that has researchers excited.

By introducing the cultures to this particular process, the stem cells were grown in suspension, eliminating the problems inherent in growing the cells on surfaces—something that has never before been accomplished. "This is an enabling technology," says Prof. Zandstra of the discovery. "[It] takes something we showed we could do before at low efficiency but not at such numbers that could be used in manufacturing."

Fluri hopes his discovery, which is "more compatible with large scale processes" will help ease the "bottleneck of cell production" used for research and drug development. The results of his research have just been released in the high profile scientific research journal, Nature Methods.

Yet there are greater implications involved in Fluri's discovery: once stem cells are produced, they are "differentiated" to become other kinds of cells—cardiac cells, for instance—and Fluri's new growing process has the potential to make this phase of cell production safer and more stable.

Fluri specifically experimented with the integrated differentiation of stem cells into cardiac cells, which could then be used for drug screening and identifying new drugs for cardiac diseases. But created in large enough numbers—and translated to human models—the process may one day be used to treat heart disease.

Explore further: From stem cells to organs: The bioengineering challenge

Related Stories

From stem cells to organs: The bioengineering challenge

February 16, 2008

For more than a decade, Peter Zandstra has been working at the University of Toronto to rev up the production of stem cells and their descendants. The raw materials are adult blood stem cells and embryonic stem cells. The ...

Study: Skin cells turned into stem cells

August 22, 2005

The controversy over embryonic stem cell research may become moot with a procedure that turns skin cells into what appear to be embryonic stem cells.

Heart derived stem cells develop into heart muscle

April 23, 2008

Dutch researchers at University Medical Center Utrecht and the Hubrecht Institute have succeeded in growing large numbers of stem cells from adult human hearts into new heart muscle cells. A breakthrough in stem cell research. ...

New study hopeful on neural stem cells

August 5, 2006

Neural stem cells derived from federally approved human embryonic cells are inferior to stem cells derived from donated fetal tissue, a new study found.

Recommended for you


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.